Tag Archives: Prostate Cancer Therapeutics Market

The prostate cancer therapeutics market is expected to grow at a CAGR of 7.3% during the forecast period of 2024 to 2032, driven by a rising incidence of prostate cancer, advancements in treatment options, and an enhanced understanding of the disease’s biology. The market is poised for continued expansion due to factors such as the increasing prevalence of prostate cancer ...